ARK Investment Management - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 39 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is 34.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q2 2020$1,110,000
+263.9%
232,172
+163.1%
0.01%
+50.0%
Q1 2020$305,000
-41.9%
88,243
-2.8%
0.01%
-38.5%
Q4 2019$525,000
+51.3%
90,748
+25.0%
0.01%
+62.5%
Q3 2019$347,000
-22.5%
72,595
+19.1%
0.01%
-27.3%
Q2 2019$448,000
+2.1%
60,948
+13.4%
0.01%
-15.4%
Q1 2019$439,000
+57.3%
53,749
+31.6%
0.01%
+18.2%
Q4 2018$279,000
-42.7%
40,844
+13.9%
0.01%
-26.7%
Q3 2018$487,00035,8460.02%
Other shareholders

There were no reported owners of GALMED PHARMACEUTICALS LTD in Q3 2018.

NameSharesValueWeighting ↓
View complete list of GALMED PHARMACEUTICALS LTD shareholders